Immunotherapy | Tumor

Antibiotics With Keytruda May Affect Survival in Non-Small Cell Lung Cancer

April 15th 2021, 1:00pm


Antibiotics, corticosteroids and proton pump inhibitors could cause negative impacts on survival in patients with non-small cell lung cancer who are receiving treatment with Keytruda.

Rozlytrek Shows Potential for Non-Small Cell Lung Cancer

March 26th 2021, 1:00pm


Rozlytrek continues to demonstrate clinical benefit for patients with ROS1 fusion-positive non-small cell lung cancer, which includes patients with central nervous system metastases.

Immunotherapy 101: What Patients Can Expect from CAR-T Cell Therapy

December 3rd 2020, 10:00pm


Chimeric antigen receptor (CAR)-T cell therapy is becoming more widely available, with two drugs approved to treat specific blood cancers and more being investigated in clinical trials across cancer types. Here’s what patients need to know if they’re considering treatment with one of these novel immunotherapies.

Mortality From COVID-19 Increases in Patients Receiving Systemic Cancer Treatments

October 14th 2020, 1:00pm


In an interview with CURE®, Dr. Trisha Wise-Draper discusses new findings that show an increased mortality risk for patients with cancer receiving systemic treatments who subsequently contracted COVID-19.

Gut Microbiome May Play an Important Role in Immunotherapy in the Future, But More Research is Needed

July 28th 2020, 10:06pm


The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.

Immunotherapy Use Not Associated with Increased Risk of Death in Patients with Cancer and COVID-19

July 22nd 2020, 7:52pm


More than half of the patients (61%) admitted to either the hospital or ICU were discharged and 12% remained in the hospital. Nine patients had died by the time data collection was cut off for this study.

Exciting Treatment Harnesses the Immune System

July 6th 2020, 10:54pm


Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.

FDA Approvals of Immunotherapy Keep Coming, Even at This Challenging Moment

July 6th 2020, 5:00pm


In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.

Staying Informed and Empowered as A Patient with Cancer

July 5th 2020, 6:00pm


Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.

Unleashing the Power Within Using Tumor-Infiltrating Lymphocyte Therapy

June 30th 2020, 7:00pm


Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.